A total of 139 patients with HNSCC from the TCGA database were included in the survival analysis and were divided into the RS for high CD27 expression (n = 70) and low CD27 expression (n = 69) groups. This evidence concerns the gene CD27 and head and neck squamous cell carcinoma.